Clinical Trials Browser

Phase 2 × tanespimycin × Breast × Clear all

NCT00096109 2017-01-16

Tanespimycin in Treating Women With Refractory Locally Advanced or Metastatic Breast Cancer

Phase 2 Terminated

11 enrolled 6 charts

Breast Neoplasms

NCT00817362 2012-12-11

Efficacy and Safety of IPI-504 With Trastuzumab Pretreated, Locally Advanced or Metastatic HER2 Positive Breast Cancer

Phase 2 Terminated

Breast Neoplasms